RadNet, Inc. (RDNT) carries a deeply negative liquidation posture as of March 31, 2026, consistent with prior periods. MFFAIS estimates cash liquidation value at approximately -$1.59B and liquid/operating liquidation value at approximately -$1.39B. The asymmetry between haircut assets and face-value liabilities drives this outcome, and the balance sheet composition has not improved under a liquidation lens during Q1 2026. The primary drivers of negative recovery are: (1) substantial goodwill and intangible assets from an ongoing acquisitions program, which receive a 0% recovery haircut under the liquidation lens; (2) total term loan debt at face value of $1.08B (Barclays Term Loan $958.7M + Truist Term Loan $120.9M, exclusive of discounts) that must be settled at face; and (3) a large and growing ASC 842 operating lease obligation embedded in the liability stack, not separately tagged in this XBRL filing but referenced extensively in the MD&A and consistent with the $35.8M quarterly building and equipment rental expense. Cash declined sharply from $767.2M at December 31, 2025 to $455.3M at March 31, 2026, a $312M reduction in one quarter. This drawdown was driven by $371.0M in investing outflows, primarily the Gleamer SAS acquisition (~$300M incremental over the prior-year quarter) plus imaging facility acquisitions totaling $67.3M. Cash remains the primary high-recovery asset on the balance sheet at 100% haircut recovery; its reduction is the single most important negative change to recovery posture this quarter. Accounts receivable at $209.1M (up from $200.3M) recovers at 90-95% and represents a stable but secondary source of recovery. PP&E carries a 50-70% haircut and has grown with the higher depreciable asset base (D&A of $38.5M in the quarter versus $32.5M in the prior year, implying a growing gross PP&E base). Goodwill and intangibles from the four Digital Health acquisitions completed since 2024 (iCAD, SeeMode, CIMAR, Gleamer) represent billions in balance sheet assets that contribute zero recovery under liquidation. The filing notes contingent consideration liabilities (non-cash change of $2.8M in Q1 2026), indicating earn-out obligations that would persist at face value through a wind-up. Working capital (exclusive of current operating lease liabilities) declined from $507.3M to $171.7M quarter-over-quarter, confirming the cash depletion. Stockholders' equity of $1.35B reflects GAAP book value but is not a proxy for liquidation recovery given the intangible-heavy asset composition. The Digital Health segment continued to burn cash operationally, posting a segment net loss of $14.9M for Q1 2026 versus $5.4M in Q1 2025, meaning its growth trajectory is consuming resources while adding intangible-heavy assets. The filing does not separately tag operating lease right-of-use assets or operating lease liabilities in XBRL TAG_CONTEXT, though both are material to the liability stack under ASC 842. Subsequent to quarter-end, the company acquired a 50% membership interest in Intermountain Medical Imaging for approximately $17.5M, adding further goodwill-generating deployment of cash post-period.
▼ Community Notes